Pharmaceuticals, Biotechnology and Life Sciences
Celltrion obtains rights for patent, trademark, approval, sales of 18 products in 9 AP markets including South Korea for USD…
Celltrion obtains rights for patent, trademark, approval, sales of 18 products in 9 AP markets including South Korea for USD…
Celltrion obtains rights for patent, trademark, approval, sales of 18 products in 9 AP markets including South Korea for USD…
− Growth & Emerging Markets Business Unit increasing focus on innovative medicines for complex and rare diseases − Continued progress…
− Growth & Emerging Markets Business Unit increasing focus on innovative medicines for complex and rare diseases − Continued progress…
− Growth & Emerging Markets Business Unit increasing focus on innovative medicines for complex and rare diseases − Continued progress…
− Growth & Emerging Markets Business Unit increasing focus on innovative medicines for complex and rare diseases − Continued progress…
− Growth & Emerging Markets Business Unit increasing focus on innovative medicines for complex and rare diseases − Continued progress…
WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and…
WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and…